| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.05T | 2.15T | 1.77T | 1.64T | 1.54T | 1.48T |
| Gross Profit | 292.30B | 237.92B | 127.40B | 147.77B | 187.74B | 218.80B |
| EBITDA | 181.50B | 136.34B | 39.18B | 66.11B | 107.03B | 140.91B |
| Net Income | 142.62B | 123.83B | 40.27B | 47.13B | 71.44B | 92.55B |
Balance Sheet | ||||||
| Total Assets | 2.61T | 2.50T | 2.58T | 2.02T | 1.96T | 1.87T |
| Cash, Cash Equivalents and Short-Term Investments | 264.40B | 300.69B | 434.71B | 415.95B | 499.11B | 494.31B |
| Total Debt | 607.88B | 317.96B | 378.53B | 202.76B | 225.23B | 219.97B |
| Total Liabilities | 1.71T | 1.59T | 1.62T | 1.18T | 1.08T | 1.03T |
| Stockholders Equity | 862.30B | 866.19B | 929.33B | 829.19B | 868.89B | 840.85B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -45.78B | -81.70B | 13.94B | 67.28B | 54.77B |
| Operating Cash Flow | 0.00 | -13.84B | 40.61B | 30.10B | 80.51B | 67.49B |
| Investing Cash Flow | 0.00 | 10.53B | -138.75B | -14.06B | -37.68B | -18.68B |
| Financing Cash Flow | 0.00 | -133.77B | 109.39B | -98.67B | -41.86B | -37.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥335.93B | 11.11 | 16.55% | 4.26% | 9.49% | 64.79% | |
75 Outperform | ¥2.53T | 10.54 | 14.23% | 2.47% | 2.27% | 70.36% | |
75 Outperform | ¥1.83T | 12.97 | 11.22% | 1.48% | 5.14% | 773.86% | |
74 Outperform | ¥272.89B | 9.47 | 7.62% | 3.44% | 7.54% | 115.47% | |
71 Outperform | ¥2.79T | 15.14 | 13.56% | 1.96% | 10.52% | 71.09% | |
67 Neutral | ¥2.54T | 15.64 | 16.64% | 1.83% | 6.60% | 114.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |